J&J’s acquisition of Auris Health has medical device giants and investors paying attention. A look at financing and market trends for the surgical robotics space.
On February 13th, Johnson & Johnson acquired Auris Health, a surgical robotics startup backed by Lux Capital, Coatue Management, Viking Global and Wellington Management, among others. Auris CEO Frederic Moll, who also co-founded competitor Intuitive Surgical, will join J&J when the deal closes.
We take a look at the Auris Health transaction to understand:
- Transaction rationale, comparable M&A transactions, and valuations
- The broader surgical robotics market landscape & market size
- Competitors & substitutes to Auris Health that may be M&A targets
- Other potential acquirers in the space